Transcatheter aortic valve replacement is cost effective compared with surgical replacement for low-risk patients
An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis and low surgical ...
Nov 8, 2021
0
11